Literature DB >> 1004641

Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine.

E Müller-Schweinitzer.   

Abstract

Changes in tension of spiral strips from dog saphenous arteries were monitored isometrically. Dose-response curves for noradrenaline, 5-HT and ergotamine were established without and after a 30 min incubation with phentolamine or pizotifen. Phentolamine was about 15 times more potent in antagonizing responses to noradrenaline (pA2 value=7.4) than those to 5-HT (pA2 value=6.2) but it was nearly equipotent in antagonizing responses to ergotamine (pA2 value=6.5) and those to 5-HT. Pizotifen was about 500 times less potent in antagonizing noradrenaline effects than 5-HT but again nearly equipotent when tested against ergotamine and 5-HT. It is suggested that in canine saphenous arteries the stimulant activity of ergotamine is mediated mainly through 5-HT receptors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1004641     DOI: 10.1007/bf00509770

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  8 in total

1.  Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters.

Authors:  J M VAN ROSSUM
Journal:  Arch Int Pharmacodyn Ther       Date:  1963

2.  pA, a new scale for the measurement of drug antagonism.

Authors:  H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1947-09

3.  Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

4.  Studies on the mechanism of the venoconstrictor activity of ergotamine on isolated canine saphenous veins.

Authors:  E Müller-Schweinitzer; E Stürmer
Journal:  Blood Vessels       Date:  1974

5.  Proceedings: Further studies on the mode of action of ergotamine on canine vein strips.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Enhanced prostaglandin synthesis contributes to the venoconstrictor activity of ergotamine.

Authors:  E Müller-Schweinitzer; J Brundell
Journal:  Blood Vessels       Date:  1975

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  Investigations on the mode of action of ergotamine in the isolated femoral vein of the dog.

Authors:  E Müller-Schweinitzer; E Stürmer
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

  8 in total
  5 in total

Review 1.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

2.  Regional differences in the responsiveness of isolated arteries from cattle, dog and man.

Authors:  E Müller-Schweinitzer; H Weidmann
Journal:  Agents Actions       Date:  1977-09

3.  Supersensitivity of atherosclerotic rabbit aorta to ergonovine. Mediation by a serotonergic mechanism.

Authors:  P D Henry; M Yokoyama
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

4.  Influence of pizotifen and ergotamine on the venoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man.

Authors:  W H Aellig
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Nitroglycerin for ergotism. Experimental studies in vitro and in migraine patients and treatment of an overt case.

Authors:  P Tfelt-Hansen; J R Ostergaard; I Gøthgen; E Jacobsen; J P Rasmussen; B Husum
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.